Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.
2.

Do you really need that heartburn med?

[No authors listed]

Johns Hopkins Med Lett Health After 50. 2010 Sep;22(7):4-5. No abstract available.

PMID:
20848752
3.

Guidance on the use of over-the-counter proton pump inhibitors for the treatment of GERD.

Holtmann G, Bigard MA, Malfertheiner P, Pounder R.

Int J Clin Pharm. 2011 Jun;33(3):493-500. doi: 10.1007/s11096-011-9489-y. Epub 2011 Apr 7.

PMID:
21472476
4.

Management of heartburn not responding to proton pump inhibitors.

Fass R, Sifrim D.

Gut. 2009 Feb;58(2):295-309. doi: 10.1136/gut.2007.145581. Review.

PMID:
19136523
5.

Hold it! Are you taking your reflux meds correctly? PPIs for heartburn and GERD are effective--but only when used according to directions.

[No authors listed]

Johns Hopkins Med Lett Health After 50. 2014 Oct;26(10):3. No abstract available.

PMID:
25306565
6.

Combination therapy.

Katz P.

Postgrad Med. 2000 May;107(5 Suppl):31-3; discussion 33-4. doi: 10.3810/pgm.5.1.2000.suppl3.17. No abstract available.

PMID:
19667512
7.

Prevalence of symptoms and use of medication for gastroesophageal reflux in an Australian community.

Watson DI, Lally CJ.

World J Surg. 2009 Jan;33(1):88-94. doi: 10.1007/s00268-008-9780-9.

PMID:
18949510
8.

Management of reflux symptoms with over-the-counter proton pump inhibitors: issues and proposed guidelines.

Haag S, Andrews JM, Katelaris PH, Gapasin J, Galmiche JP, Hunt R, Layer P, Malfertheiner P, Holtmann G.

Digestion. 2009;80(4):226-34. doi: 10.1159/000235953. Epub 2009 Oct 16. Review.

PMID:
19844107
9.

Nocturnal gastroesophageal reflux disease: issues, implications, and management strategies.

Johnson DA, Katz PO.

Rev Gastroenterol Disord. 2008 Spring;8(2):98-108. Review.

PMID:
18641592
10.

Inappropriate use of proton pump inhibitors.

Molloy D, Molloy A, O'Loughlin C, Falconer M, Hennessy M.

Ir J Med Sci. 2010 Mar;179(1):73-5. doi: 10.1007/s11845-009-0426-1. Epub 2009 Sep 11.

PMID:
19763673
11.

Algorithmic approach to patients presenting with heartburn and epigastric pain refractory to empiric proton pump inhibitor therapy.

Roorda AK, Marcus SN, Triadafilopoulos G.

Dig Dis Sci. 2011 Oct;56(10):2871-8. doi: 10.1007/s10620-011-1708-9. Epub 2011 Apr 22.

PMID:
21512760
12.

Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease.

Kahrilas PJ, Howden CW, Hughes N.

Am J Gastroenterol. 2011 Aug;106(8):1419-25; quiz 1426. doi: 10.1038/ajg.2011.146. Epub 2011 May 3. Review.

PMID:
21537361
13.

The safety of proton pump inhibitors (PPIs) in pregnancy: a meta-analysis.

Gill SK, O'Brien L, Einarson TR, Koren G.

Am J Gastroenterol. 2009 Jun;104(6):1541-5; quiz 1540, 1546. doi: 10.1038/ajg.2009.122. Epub 2009 Apr 28. Review.

PMID:
19491869
14.

Proton pump inhibitors: are they overutilised in clinical practice and do they pose significant risk?

Heidelbaugh JJ, Metz DC, Yang YX.

Int J Clin Pract. 2012 Jun;66(6):582-91. doi: 10.1111/j.1742-1241.2012.02921.x. Review.

15.

Esophageal acid exposure on proton pump inhibitors in unselected asymptomatic gastroesophageal reflux disease patients.

Grigolon A, Cantù P, Savojardo D, Conte D, Penagini R.

J Clin Gastroenterol. 2008 Oct;42(9):969-73. doi: 10.1097/MCG.0b013e31814b8fc2.

PMID:
18719508
16.

The proton pump inhibitor test and the diagnosis of gastroesophageal reflux disease.

Pace F, Pace M.

Expert Rev Gastroenterol Hepatol. 2010 Aug;4(4):423-7. doi: 10.1586/egh.10.38.

PMID:
20678016
17.

Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors.

Zerbib F, Duriez A, Roman S, Capdepont M, Mion F.

Gut. 2008 Feb;57(2):156-60. Epub 2007 Oct 19.

PMID:
17951358
18.

Weakly acidic refluxes have a major role in the pathogenesis of proton pump inhibitor-resistant reflux oesophagitis.

Frazzoni M, Conigliaro R, Melotti G.

Aliment Pharmacol Ther. 2011 Mar;33(5):601-6. doi: 10.1111/j.1365-2036.2010.04550.x. Epub 2010 Dec 29.

19.

Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.

Higginbotham TW.

Ann Pharmacother. 2010 Mar;44(3):572-6. doi: 10.1345/aph.1M519. Epub 2010 Feb 2. Review.

PMID:
20124466
20.

Frequency and clinical implications of supraesophageal and dyspeptic symptoms in gastroesophageal reflux disease.

Mearin F, Ponce J, Ponce M, Balboa A, Gónzalez MA, Zapardiel J.

Eur J Gastroenterol Hepatol. 2012 Jun;24(6):665-74. doi: 10.1097/MEG.0b013e3283512139.

PMID:
22330237

Supplemental Content

Support Center